Last edition
News about
NPPA Extends Price Cap on Orthopaedic Knee Implants Until November 15, 2025
The National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price on orthopaedic knee implants for knee replacement systems by two months, pushing the deadline to 15 November 2025. The ceiling price, originally imposed in August 2017 in public interest, had been extended periodically, most recently up to 15 September 2025.
Greenwich LifeSciences Expands Flamingo-01 Breast Cancer Trial to Ireland
Greenwich LifeSciences has expanded its Phase III clinical trial, FLAMINGO-01, evaluating GLSI-100, an immunotherapy aimed at preventing breast cancer recurrences, to Ireland.
Aurobindo Pharma Expands Business in Malaysia with New Subsidiary
Aurobindo Pharma has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma (Malaysia) SDN. BHD., through its subsidiary Helix Healthcare B.V.
Roche to Acquire 89bio in Deal Worth Up to USD 3.5 Billion
Roche has entered into a merger agreement to acquire 89bio, a San Francisco-based clinical-stage biopharmaceutical company focused on developing innovative therapies for liver and cardiometabolic diseases.
European Commission approves EYLUXVI (ALT-L9) by Alteogen
EYLUXVI is the second biosimilar approved by the European Commission for Alteogen, following the launch of the Herceptin biosimilar in China through its partner Qilu Pharmaceutical.
AltrixBio Raises USD 5 Million Series A Financing and Appoints David Pass as CEO
Dr David Pass, a veteran of the pharma, biotech, and medical device sectors with a track record of scaling programs to over USD 1 billion in sales, succeeds AltrixBio Co-Founder and CEO Nancy Briefs, who led the company from inception and will now serve as Executive Chair.
India Now Among Top Global Reporters of Drug Adverse Events, Says DCGI
India has emerged as one of the top global contributors in reporting adverse drug events, according to Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI). He made the remarks during the inauguration of the 5th National Pharmacovigilance Week in New Delhi.
Mankind Pharma Partners with OpenAI to Embed AI Across Operations
Mankind Pharma has announced a strategic collaboration with OpenAI, aimed at integrating artificial intelligence across its entire value chain. The move marks one of the first times an Indian pharmaceutical company has committed to fully embedding advanced AI into its core operations.
Orforglipron by Lily Shows Significant Weight Loss and Cardiometabolic Gains in ATTAIN-1 Results
Orforglipron by Eli Lily demonstrated significant improvements across key cardiometabolic risk factors, supporting its potential as a treatment option for millions living with obesity.
Gerresheimer and Portal Instruments Strengthen Alliance for PRIME NEXUS Reusable Autoinjector
Gerresheimer is expanding its collaboration with medical device company Portal Instruments to commercialise the Prime NEXUS reusable, connected autoinjector platform.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy